New surgery improves head and neck cancer treatment

A new surgical procedure for head and neck cancer at the University of Alabama at Birmingham offers improved accuracy for surgeons and reduced post-operative pain for patients.

The new procedure uses robotic surgery, and results have shown it lessens the scarring, breathing problems and damage to speech that can happen with treating head and neck cancers, said William Carroll, M.D., a scientist in the UAB Comprehensive Cancer Center.

Initial tests have shown the new procedure also shortens recovery times for cancer patients.

"This application takes robotic surgery to new places in the body," said Carroll, a head and neck surgeon within UAB's Division of Otolaryngology, and one of the first surgeons to begin using the procedure for head and neck cancers.

"There is an option for patients to have a more minimally invasive surgery, and one that could effectively remove the cancer while causing fewer side effects," he said.

Robotic surgery is an alternative to traditional open surgery and a refinement on the concept of laparoscopic surgery, Carroll said. The robot most commonly used in cancer treatment is called the da Vinci, which is sold by Intuitive Surgical.

UAB was the first medical center in Alabama and among the first in the United States to begin using the da Vinci for head and neck cancers more than a year ago. Since that time, 40 UAB patients have had the new operation.

Offering the new procedure to patients first involved adapting operating techniques and robot-arm positions, and continually refining those adaptations, Carroll said. The da Vinci was originally designed for operating on the lower and middle sections of the body, not the narrow spaces inside the head and neck.

The increased surgical accuracy comes from tiny cameras attached to the end of the da Vinci instruments. Carroll said the magnified, 3-D image gives doctors a greater field of vision than conventional open or laparoscopic surgery.

This year more than 40,000 Americans will be diagnosed with head and neck cancer, and more than 7,500 will die from the disease, according to the American Cancer Society. The disease includes cancers of the oral cavity, and the larynx and pharynx.

The most effective prevention strategy remains stopping risky behaviors like smoking, chewing tobacco or drinking excessive alcohol, Carroll said.

Source: University of Alabama at Birmingham

Related stories:

Skin flaps deliver cancer-fighting therapy, ASPS study reveals
Using gene therapy, plastic surgeons have delivered cancer fighting proteins through skin flaps placed on cancerous tumors on rats with a 79 percent reduction in tumor volume, according to a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS). This new delivery technique, which has yet to be tested in humans, did not cause toxicity in the body of rats; however, administering the same anti-tumor agent intravenously in humans has previously been shown to cause liver damage.
New genetic techniques to combat lung cancer
New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.
New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks
A drug that targets the cell surface receptors that play an important role in many types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today. Dr. Angel Rodriguez, from the Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, USA, said that the work demonstrated for the first time that the tyrosine kinase inhibitor lapatinib could decrease tumour-causing breast cancer stem cells in the primary breast cancers of women receiving neoadjuvant treatment (treatment given before the primary surgery for the disease).
HPV, periodontitis work in tandem to increase risk of tongue cancer
Persons with periodontitis who also are infected with human papillomavirus (HPV) are at increased risk of developing tongue cancer, new research conducted at the University at Buffalo School of Dental Medicine has shown.
MRI's high false positive rate has little impact on women's choice of preventive mastectomy
Magnetic resonance imaging (MRI) falsely detects breast cancer in five out of every six positive scans according to new research into the use of MRI for women with a high, inherited risk of developing the disease. However, this high rate of false positives does not have a major impact on a woman’s decision whether or not to have a prophylactic mastectomy.
Study examines changes in quality of life after head and neck cancer treatment
In the year following their first treatment, patients with head and neck cancer report declines in their physical quality of life but improvements in their mental health quality of life, according to a report in the March issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals. Some types of treatment—especially feeding tube placement, chemotherapy and radiation therapy—were associated with changes in quality of life.
Small study shows marijuana does not increase risk of head, neck cancer
Smoking marijuana (cannabis) does not increase the user’s risk of head and neck cancer, according to a new study published in the March 2008 issue of Otolaryngology – Head and Neck Surgery.
PET outperforms CT in characterization of lung nodules
Researchers involved in a large, multi-institutional study comparing the accuracy of positron emission tomography (PET) and computed tomography (CT) in the characterization of lung nodules found that PET was far more reliable in detecting whether or not a nodule was malignant.

News discussion:

Medicine & Health news